View More View Less
  • 1 Pécsi Tudományegyetem, Általános Orvostudományi Kar, Pécs, Rét u. 2., 7623
  • 2 Pécsi Tudományegyetem, Általános Orvostudományi Kar, Pécs
  • 3 Pécsi Tudományegyetem, Általános Orvostudományi Kar, Pécs
  • 4 Pécsi Tudományegyetem, Gyógyszerésztudományi Kar, Pécs
Open access

Absztrakt:

A repetitív transcranialis mágneses stimulációs eljárás egy olyan neuromodulációs technika, melynek gyorsan fejlődő területe jelentheti az egyik biztonságos, alternatív megközelítési módot bizonyos mentális zavarok, elsősorban a terápiarezisztens major depresszív zavar kezelésében. Célunk a transcranialis mágneses stimulációs kezelés jelenlegi kutatási és klinikai alkalmazási lehetőségeinek bemutatása a szakirodalmi adatok és a klinikai gyakorlat áttekintése alapján. Mióta ismertté vált, hogy külső mágneses forrással neuronok depolarizálhatók, mind a neurológia, mind a pszichiátria az eljárás lehetséges klinikai használatát kutatja. Napjainkig a módszer a pszichiátria területén belül a major depresszív zavar és a kényszeres zavar kezelésében engedélyezett, de egyéb betegségek (például szkizofrénia, bipoláris zavar) kezelésében is kutatják lehetséges alkalmazását. A transcranialis mágneses stimulációs rendszerek fejlesztésének következő lépcsőjét jelenti a mágnesesrezonancia-felvétel alapján, helymeghatározó algoritmusok segítségével, valós időben navigált mágneses stimulációs készülékek kidolgozása. Az úgynevezett neuronavigációs rendszerek lehetővé teszik a depresszió kialakulásáért felelős idegi hálózatok pontos célzását, így a dorsolateralis praefrontalis kéreg excitabilitásának fokozását a bal féltekén és csökkentését a jobb féltekén. Az eljárás kevés kontraindikációval bír, és a megfelelő körültekintéssel választott indikáció és betegpopuláció esetén mellékhatások is alacsony számban jelentkeznek. A transcranialis mágneses stimulációs kezelés mára bizonyítottan hatékony módszerré vált bizonyos mentális zavarok, elsősorban a terápiarezisztens major depresszív zavar kezelésében. A jövőben a neuronavigációs neuromodulációs kezelések, azon belül is a repetitív transcranialis mágneses stimulációs kezelés térhódítása várható a pszichiátria és a neurológia területén. Jelenleg Magyarországon több centrumban is végeznek különböző indikációkban mágneses stimulációs kezeléseket, ám az eljárás mentális zavarokban történő alkalmazásának finanszírozási befogadása és beépítése a mindennapi klinikai gyakorlatba még várat magára. Orv Hetil. 2020; 161(1): 3–10.

If the inline PDF is not rendering correctly, you can download the PDF file here.

  • 1

    Barker AT, Jalinous R, Freeston IL. Non-invasive magnetic stimulation of human motor cortex. Lancet 1985; 325: 1106–1107.

  • 2

    Uozumi T, Tsuji S, Murai Y. Motor potentials evoked by magnetic stimulation of the motor cortex in normal subjects and patients with motor disorders. Electroencephalogr Clin Neurophysiol. 1991; 81: 251–256.

  • 3

    Davey K, Epstein CM. Magnetic stimulation coil and circuit design. IEEE Trans Biomed Eng. 2000; 47: 1493–1499.

  • 4

    Deng ZD, Lisanby SH, Peterchev AV. Electric field depth–focality tradeoff in transcranial magnetic stimulation: simulation comparison of 50 coil designs. Brain Stimul. 2013; 6: 1–13.

  • 5

    Bersani FS, Minichino A, Enticott PG. Deep transcranial magnetic stimulation as a treatment for psychiatric disorders: a comprehensive review. Eur Psychiatry 2013; 28: 30–39.

  • 6

    Chen R, Classen J, Gerloff C, et al. Depression of motor cortex excitability by low-frequency transcranial magnetic stimulation. Neurology 1997; 48: 1398–1403.

  • 7

    Pascual-Leone A, Valls-Solé J, Wassermann E. Responses to rapid-rate transcranial magnetic stimulation of the human motor cortex. Brain 1994; 117: 847–858.

  • 8

    Greicius MD, Flores BH, Menon V, et al. Resting-state functional connectivity in major depression: abnormally increased contributions from subgenual cingulate cortex and thalamus. Biol Psychiatry 2007; 62: 429–437.

  • 9

    Mayberg HS. Modulating dysfunctional limbic-cortical circuits in depression: towards development of brain-based algorithms for diagnosis and optimised treatment. Br Med Bull. 2003; 65: 193–207.

  • 10

    Drevets WC, Price JL, Furey ML. Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression. Brain Struct Funct. 2008; 213: 93–118.

  • 11

    Schutter DJ. Antidepressant efficacy of high-frequency transcranial magnetic stimulation over the left dorsolateral prefrontal cortex in double-blind sham-controlled designs: a meta-analysis. Psychol Med. 2009; 39: 65–75.

  • 12

    Schutter DJ. Quantitative review of the efficacy of slow-frequency magnetic brain stimulation in major depressive disorder. Psychol Med. 2010; 40: 1789–1795.

  • 13

    Murrough JW, Iacoviello B, Neumeister A, et al. Cognitive dysfunction in depression: neurocircuitry and new therapeutic strategies. Neurobiol Learn Mem. 2011; 96: 553–563.

  • 14

    Mayberg HS, Liotti M, Brannan SK, et al. Reciprocal limbic-cortical function and negative mood: converging PET findings in depression and normal sadness. Am J Psychiatry 1999; 156: 675–682.

  • 15

    Gur E, Lerer B, Dremencov E, et al. Chronic repetitive transcranial magnetic stimulation induces subsensitivity of presynaptic serotonergic autoreceptor activity in rat brain. Neuroreport 2000; 11: 2925–2929.

  • 16

    Keck ME, Welt T, Post A, et al. Neuroendocrine and behavioral effects of repetitive transcranial magnetic stimulation in a psychopathological animal model are suggestive of antidepressant-like effects. Neuropsychopharmacology 2001; 24: 337–349.

  • 17

    Post A, Müller MB, Engelmann M, et al. Repetitive transcranial magnetic stimulation in rats: evidence for neuroprotective effects in vitro and in vivo. Eur J Neurosci. 1999; 11: 3247–3254.

  • 18

    O’Reardon JP, Solvason HB, Janicak PG. Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial. Biol Psychiatry 2007; 62: 1208–1216.

  • 19

    Shawn M, Irving MR, Linda LC, et al. Consensus recommendations for the clinical application of repetitive transcranial magnetic stimulation (rTMS) in the treatment of depression. J Clin Psychiatry 2018; 79(1): 16cs10905.

  • 20

    Levkovitz Y, Isserles M, Padberg F, et al. Efficacy and safety of deep transcranial magnetic stimulation for major depression: a prospective multicenter randomized controlled trial. World Psychiatry 2015; 14: 64–73.

  • 21

    Nguyen K-H, Gordon LG. Cost-effectiveness of repetitive transcranial magnetic stimulation versus antidepressant therapy for treatment-resistant depression. Value Health 2015; 18: 597–604.

  • 22

    Simpson KN, Welch MJ, Kozel FA, et al. Cost-effectiveness of transcranial magnetic stimulation in the treatment of major depression: a health economics analysis. Adv Ther. 2009; 26: 346–368.

  • 23

    Voigt J, Carpenter L, Leuchter A. Cost effectiveness analysis comparing repetitive transcranial magnetic stimulation to antidepressant medications after a first treatment failure for major depressive disorder in newly diagnosed patients – a lifetime analysis. PLoS ONE 2017; 12: e0186950.

  • 24

    Greden JF, Riba MB, McInnis MG, et al. Treatment resistant depression: a roadmap for effective care. American Psychiatric Publishing, Arlington, VA, 2011; pp. 3.

  • 25

    Berlim MT, Turecki G. Definition, assessment, and staging of treatment-resistant refractory major depression: a review of current concepts and methods. Can J Psychiatry 2007; 52: 46–54.

  • 26

    Warden D, Rush AJ, Trivedi MH, et al. The STAR*D project results: a comprehensive review of findings. Curr Psychiatry Rep. 2007; 9: 449–459.

  • 27

    Philip NS, Dunner DL, Dowd SM, et al. Can medication free, treatment-resistant, depressed patients who initially respond to TMS be maintained off medications? A prospective, 12-month multisite randomized pilot study. Brain Stimul. 2016; 9: 251–257.

  • 28

    Pal E, Nagy F, Achermann Z, et al. The impact of left prefrontal repetitive transcranial magnetic stimulation on depression in Parkinson’s disease: a randomized, double-blind, placebo-controlled study. Mov Disord. 2010; 25: 2311–2317.

  • 29

    Wall CA, Croarkin PE, Sim LA, et al. Adjunctive use of repetitive transcranial magnetic stimulation in depressed adolescents: a prospective, open pilot study. J Clin Psychiatry 2011; 72: 1263–1269.

  • 30

    Kim DR, Epperson N, Paré E, et al. An open label pilot study of transcranial magnetic stimulation for pregnant women with major depressive disorder. J Womens Health 2011; 20: 255–261.

  • 31

    Harel EV, Zangen A, Roth Y, et al. H-coil repetitive transcranial magnetic stimulation for the treatment of bipolar depression: an add-on, safety and feasibility study. World J Biol Psychiatry 2011; 12: 119–126.

  • 32

    Barr MS, Farzan F, Tran LC, et al. A randomized controlled trial of sequentially bilateral prefrontal cortex repetitive transcranial magnetic stimulation in the treatment of negative symptoms in schizophrenia. Brain Stimulat. 2012; 5: 337–346.

  • 33

    Rostami R, Kazemi R, Nitsche MA, et al. Clinical and demographic predictors of response to rTMS treatment in unipolar and bipolar depressive disorders. Clin Neurophysiol. 2017; 128: 1961–1970.

  • 34

    Dlabac-de Lange JJ, Liemburg EJ, Bais L, et al. Effect of bilateral prefrontal rTMS on left prefrontal NAA and Glx levels in schizophrenia patients with predominant negative symptoms: an exploratory study. Brain Stimul. 2017; 10: 59–64.

  • 35

    Rossi S, Hallett M, Rossini PM, et al., The Safety of TMS Consensus Group. Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research. Clin Neurophysiol. 2009; 120: 2008–2039.

  • 36

    Hsieh TH, Dhamne SC, Chen JJ, et al. Minimal heating of aneurysm clips during repetitive transcranial magnetic stimulation. Clin Neurophysiol. 2012; 123: 1471–1473.

  • 37

    Deng ZD, Lisanby SH, Peterchev AV. Transcranial magnetic stimulation in the presence of deep brain stimulation implants: induced electrode currents. Conf Proc IEEE Eng Med Biol Soc. 2010; 2010: 6821–6824.

  • 38

    Janicak PG, O’Reardon JP, Sampson SM, et al. Transcranial magnetic stimulation in the treatment of major depressive disorder: a comprehensive summary of safety experience from acute exposure, extended exposure, and during reintroduction to treatment. J Clin Psychiatry 2008; 69: 222–232.

  • 39

    Dobek CE, Blumberger DM, Downar J, et al. Risk of seizures in transcranial magnetic stimulation: a clinical review to inform consent process focused on bupropion. Neuropsychiatr Dis Treat. 2015; 11: 2975–2987.

  • 40

    Bermudes RA, Lanocha KI, Janicak PG. Transcranial magnetic stimulation: clinical applications for psychiatric practice. American Psychiatric Publishing, Arlington, VA, 2017.

  • 41

    Dunner DL, Aaronson ST, Sackeim HA, et al. A multisite, naturalistic, observational study of transcranial magnetic stimulation for patients with pharmacoresistant major depressive disorder: durability of benefit over a 1-year follow-up period. J Clin Psychiatry 2014; 75: 1394–1401.

  • 42

    Sommer M, Wu T, Tergau F, et al. Intra- and interindividual variability of motor responses to repetitive transcranial magnetic stimulation. Clin Neurophysiol. 2002; 113: 265–269.

  • 43

    Awiszus A. TMS and threshold hunting. Suppl Clin Neurophysiol. 2003; 56: 13–23.

  • 44

    Talairach J, Tournoux P. Co-planar stereotaxic atlas of the human brain. Thieme, Stuttgart, 1988.

  • 45

    Lefaucheur J-P, André-Obadia N, Antal A. Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS). Clin Neurophysiology 2014; 125: 2150–2206.

  • 46

    Berlim MT, Van den Eynde F, Daskalakis J. Clinically meaningful efficacy and acceptability of low-frequency repetitive transcranial magnetic stimulation (rTMS) for treating primary major depression: a meta-analysis of randomized, double-blind and sham-controlled trials. Neuropsychopharmacology 2013; 38: 543–551.

  • 47

    Németh VL, Csifcsák G, Kincses ZT, et al. The terapeutic use of transcranial magnetic stimulation in major depression. [Transcranialis mágneses stimuláció terápiás alkalmazása major depresszióban]. Ideggyógy Szle. 2016; 69: 89–97. [Hungarian]

  • 48

    Blumberger DM, Vila-Rodriguez F, Thorpe KE, et al. Effectiveness of theta burst versus high-frequency repetitive transcranial magnetic stimulation in patients with depression (THREE-D): a randomised non-inferiority trial. Lancet 2018; 391: 1683–1692.

  • 49

    Schulze L, Remington G, Giacobbe P, et al. Effect of antipsychotic pharmacotherapy on clinical outcomes of intermittent theta-burst stimulation for refractory depression. J Psychopharmacol. 2017; 31: 312–319.

  • 50

    Herwig U, Padberg F, Unger J, et al. Transcranial magnetic stimulation in therapy studies: examination of the reliability of “standard” coil positioning by neuronavigation. Biol Psychiatry 2001; 50: 58–61.

  • 51

    Schönfeldt-Lecuona C, Lefaucheur J-P, Cardenas-Morales L, et al. The value of neuronavigated rTMS for the treatment of depression. Neurophysiol Clin. 2010; 40: 37–43.

  • 52

    Paillère Martinot ML, Galinowski A, Ringuenet D, et al. Influence of prefrontal target region on the efficacy of repetitive transcranial magnetic stimulation in patients with medication-resistant depression: a [18F]-fluorodeoxyglucose-PET and MRI study. Int J Neuropsychopharmacol. 2010; 13: 45–59.

  • 53

    Perera T, George MS, Grammer G, et al. The Clinical TMS Society consensus review and treatment recommendations for TMS therapy for major depressive disorder. Brain Stimul. 2016; 9: 336–346.

  • 54

    Fitzgerald PB, Hoy KE, Anderson RJ, et al. A study of the pattern of response to rTMS treatment in depression. Depress Anxiety 2016; 33: 746–753.

  • 55

    Berlim MT, Van den Eynde F, Tovar-Perdomo S, et al. Augmenting antidepressants with deep transcranial magnetive stimulation (DTMS) in treatment-resistant major depression. World J Biol Psychiatry 2014; 15: 570–578.

  • 56

    Vedeniapin A, Cheng L, George MS. Feasibility of simultaneous cognitive behavioral therapy and left prefrontal rTMS for treatment resistant depression. Brain Stimulat. 2010; 3: 207–210.

The author instructions are available in PDF.
Instructions for Authors in Hungarian HERE.

Mendeley citation style is available HERE.

 

MANUSCRIPT SUBMISSION

  • Impact Factor (2018): 0.564
  • Medicine (miscellaneous) SJR Quartile Score (2018): Q3
  • Scimago Journal Rank (2018): 0.193
  • SJR Hirsch-Index (2018): 18

Language: Hungarian

Founded in 1857
Publication: Weekly, one volume of 52 issues annually

Senior editors

Editor(s)-in-Chief: Papp Zoltán

Read the professional career of Papp Zoltán HERE.

 

Editorial Board

Click for the Editorial Board

Akadémiai Kiadó
Address: Prielle Kornélia u. 21-35. H-1117 Budapest, Hungary
Phone: (+36 1) 464 8235 ---- Fax: (+36 1) 464 8221
Email: orvosihetilap@akkrt.hu